Closure Omnex Helps Seal 20% Stock Rebound In October – OTC Index
This article was originally published in The Gray Sheet
Executive Summary
Investor optimism that Closure Medical will achieve strong revenue growth following the pending launch of its Omnex surgical vascular sealant in Europe helped the firm's stock rise 19.8% to $17.06 in October